Publications Database

Armenteros J. et al. (1995)

Haloperidol-related dyskinesias and pre- and perinatal complications in autistic children.

Psychopharmacology Bulletin

31(2), pp. 363-369

Read Abstract (New Window)

Campbell M. et al. (1990)

Naltrexone in autistic children: a double-blind and placebo-controlled study.

Psychopharmacology Bulletin

26(1), pp. 130-135

Read Abstract (New Window)

Campbell M. (1998)

Naltrexone in infantile autism.

Psychopharmacology Bulletin

24(1), pp. 135-139

Campbell M. et al. (1986)

Short-term efficacy and safety of fenfluramine in hospitalized preschool-age autistic children: an open study.

Psychopharmacology Bulletin

22(1), pp. 141-147

Campbell M. et al. (1990)

Stereotypies and tardive dyskinesia: abnormal movements in autistic children.

Psychopharmacology Bulletin

26(2), pp. 260-266

Read Abstract (New Window)

DeFilippis M. (2018)

The use of complementary alternative medicine in children and adolescents with autism spectrum disorder.

Psychopharmacology Bulletin

48(1), pp. 40-63.

Read Abstract (New Window) Read Full (New Window)

Ernst M. et al. (1993)

Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children.

Psychopharmacology Bulletin

29(2), pp. 221-227

Read Abstract (New Window)

Findling R. L. , Maxwell K. , Wiznitzer M. (1997)

An open clinical trial of risperidone monotherapy in young children with autistic disorder.

Psychopharmacology Bulletin

33(1), pp. 155-159

Read Abstract (New Window)

Ghanizadeh A. (2009)

Does risperidone improve hyperacusia in children with autism?

Psychopharmacology Bulletin

42(1), pp. 108-110

Read Abstract (New Window)

Gonzalez N. M. et al. (1994)

Naltrexone plasma levels, clinical response and effect on weight in autistic children.

Psychopharmacology Bulletin

30(2), pp. 203-208

Read Abstract (New Window)

Locascio J. et al. (1991)

Factors related to haloperidol response and dyskinesias in autistic children.

Psychopharmacology Bulletin

27(2), pp. 119-126

Malone R. P. et al. (1991)

Repeated episodes of neuroleptic-related dyskinesias in autistic children.

Psychopharmacology Bulletin

27(2), pp. 113-117

Read Abstract (New Window)

Sanchez L. e. et al. (1995)

A comparison of live and videotape ratings: clomipramine and haloperidol in autism.

Psychopharmacology Bulletin

31(2), pp. 371-378.

Read Abstract (New Window)

Silva R. R. et al. (1993)

Haloperidol withdrawal and weight changes in autistic children.

Psychopharmacology Bulletin

29(2), pp. 287-291

Read Abstract (New Window)